Search Results 791-800 of 18303 for prostate cancer

  1. Mayo Clinic researchers present advances in immunotherapy, biomarkers and tumor biology at AACR 2026

    ... prostate tumor microenvironment. The findings have the potential to yield new immunotherapeutic approaches for prostate cancer treatment. Presenter: Casey ...

  2. A Study to Determine Frequency of DNA-repair Defects in Men With Metastatic Prostate Cancer - Mayo Clinic

    The purpose of this study is to evaluate the prevalence of 4 or more DNA-repair defects in a population of men with metastatic Prostate Cancer (PC), and to use ...

  3. Apalutamide (oral route) - Side effects & dosage - Mayo Clinic

    Apalutamide is used to treat patients with metastatic castration-sensitive prostate cancer (prostate cancer that responds to medical or surgical treatments ...

  4. Clinical trials - Oncology (Medical)

    This is an open label, phase I/II, multi-center study in adult participants with metastatic hormone sensitive prostate cancer (mHSPC) and with metastatic ...

  5. Study Of Cabozantinib Combined With Atezolizumab Vs. Second Novel Hormonal Therapy In Subjects With Metastatic Castration-Resistant Prostate Cancer - Mayo Clinic

    ... prostate cancer (mCRPC) who have previously been treated with one, and only one, NHT for their prostate cancer disease. Participation eligibility.

  6. Jack R. Andrews, M.D. - Mayo Clinic Faculty Profiles

    ... prostate cancer, expanding active surveillance and biomarker development. PSMA therapy uses a radioactive material to kill prostate cancer cells.

  7. A Study Of Carboplatin, Cabazitaxel And Abiraterone In High Volume Metastatic Castration Sensitive Prostate Cancer (CASCARA) - Mayo Clinic

    A Study Of Carboplatin, Cabazitaxel And Abiraterone In High Volume Metastatic Castration Sensitive Prostate Cancer (CASCARA) · More about research at Mayo Clinic.

  8. Jacob J. Orme, M.D., Ph.D. - Doctors and Medical Staff - Mayo Clinic

    Dr. Orme has received awards from Mayo Clinic, the Minnesota Society of Clinical Oncology, the National Institutes of Health, and the Prostate Cancer Foundation ...

  9. Clinical trials - Oncology (Medical)

    This is an open label, phase I/II, multi-center study in adult participants with metastatic hormone sensitive prostate cancer (mHSPC) and with metastatic ...

  10. Cynthia Weiss Archives - Mayo Clinic News Network

    Prostate cancer screening. September is National Prostate Cancer Awareness Month. Cancer screening tests, including the prostate-specific antigen (PSA) test ...